The Egyptian Drug Authority approved the insulin glargine injection manufactured by EVA Pharma through a collaboration with Eli Lilly (LLY). Launched in 2022, the collaboration aims to deliver a ...
This milestone stems from the companies' collaboration to expand access to affordable insulin to one million people living with diabetes in low- to middle-income countries annually by 2030 This marks ...
Building upon earlier discoveries continues to produce ever-better diabetes treatments. Molecules of insulin—a hormone that regulates blood glucose, or sugar—circulate in the blood stream, ensuring ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results